Table 3

Frequent copy number and expression altered genes1.

GAINED AND OVEREXPRESSED GENES

SYMBOL
GENE DESCRIPTION
%
MEDIAN
LOCATION

ATP2B4
ATPase, Ca++ transporting, plasma membrane 4
20.00
1.17
1q25-q32
LOC153222
Adult retina protein
25.00
1.32
5
GBAS
Glioblastoma amplified sequence
20.00
1.61
7p12
GUSB
Glucuronidase, beta
20.00
1.42
7q21.11
RFC2
Replication factor C (activator 1) 2, 40kDa
26.32
1.06
7q11.23
MCM7
MCM7 minichromosome maintenance deficient 7 (S. cerevisiae)
35.29
1.02
7q21.3-q22.1
GIMAP6
GTPase, IMAP family member 6
20.00
1.29

LR8
LR8 protein
21.05
2.34
7q36.1
APOE
Apolipoprotein E
22.22
1.48
19q13.2
EMP3
Epithelial membrane protein 3
33.33
1.36
19q13.3
FPR1
Formyl peptide receptor 1
25.00
1.94
19q13.4

LOST AND UNDEREXPRESSED GENES

SYMBOL
GENE DESCRIPTION
%
MEDIAN
LOCATION

CYP1B1
Cytochrome P450, family 1, subfamily B, polypeptide 1
21.05
-2.87
2p21
TDE2
Tumor differentially expressed 2
23.53
-1.86
6q22.32
OPTN
Optineurin
41.18
-1.86
10p14
DNAJC12
DnaJ (Hsp40) homolog, subfamily C, member 12
25.00
-1.16
10
SIRT1
Sirtuin (silent mating type information regulation 2 homolog) 1
27.27
-1.27
10q22.1
PPP3CB
Protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform
35.00
-2.08
10q21-q22
GHITM
Growth hormone inducible transmembrane protein
37.50
-1.55
10q23.2
CYP26A1
Cytochrome P450, family 26, subfamily A, polypeptide 1
21.05
-1.08
10q23-q24
LGI1
Leucine-rich, glioma inactivated 1
45.00
-1.32
10q24
SLK
STE20-like kinase (yeast)
26.32
-1.11
10q25.1
ADD3
Adducin 3 (gamma)
68.42
-1.04
10q24.2-q24.3
MXI1
MAX interactor 1
40.00
-1.11
10q24-q25
ATRNL1
Attractin-like 1
30.77
-1.65
10
KIAA1598
KIAA1598
21.05
-1.83
10q26.12
NDFIP2
Nedd4 family interacting protein 2
33.33
-1.22
13q22.2
MAP2K4
Mitogen-activated protein kinase kinase 4
23.53
-1.30
17p11.2
DSG2
Desmoglein 2
31.25
-1.94
18q12.1
TPTE
Transmembrane phosphatase with tensin homology
22.22
-1.67
21p11

1Percentage of tumors showing copy number and expression alterations (%). Median of expression log2 ratios of copy number altered genes (median).

Ruano et al. Molecular Cancer 2006 5:39   doi:10.1186/1476-4598-5-39